The Current Landscape of Immune Checkpoint Blockade in Metastatic Lung Squamous Cell Carcinoma

In addition to surgery, chemotherapy, radiotherapy, and targeted therapy, immunotherapy has emerged as a standard pillar of cancer treatment. Immune checkpoint inhibitors (ICIs) such as targeting programmed death-1/programmed death ligand 1 (PD-1/PD-L1) and cytotoxic T lymphocyte antigen 4 (CTLA-4)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Hong, Liu, Jing, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961875/
https://www.ncbi.nlm.nih.gov/pubmed/33807509
http://dx.doi.org/10.3390/molecules26051392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961875/
https://www.ncbi.nlm.nih.gov/pubmed/33807509
http://dx.doi.org/10.3390/molecules26051392

Ejemplares similares